上海医药(02607):溴吡斯的明口服溶液获得批准生产
智通财经网·2026-01-09 09:48

Core Viewpoint - Shanghai Pharmaceuticals has received approval from the National Medical Products Administration for the production of bromhexine oral solution, indicating a significant advancement in its product portfolio [1] Group 1 - Shanghai Pharmaceuticals Group Co., Ltd. announced that its subsidiary, Shanghai Shiyou Chinese-Western Medicine Co., Ltd., has obtained a drug registration certificate for bromhexine oral solution [1] - The drug registration certificate number is 2025S04074, confirming the approval for production [1]

Shanghai Pharma-上海医药(02607):溴吡斯的明口服溶液获得批准生产 - Reportify